FindTrial
Sign In

A multicenter study assessing the prevalence of allergy in Chinese population

A multicenter study assessing the prevalence of allergy in Chinese population

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800017021
Enrollment
Unknown
Registered
2018-07-09
Start date
2018-09-01
Completion date
Unknown
Last updated
2018-07-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

allergic rhinitis

Interventions

allergic rhinitis with or without asthma:none

Sponsors

The First Affiliated Hospital of Guangzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
5 Years to 60 Years

Inclusion criteria

Inclusion criteria: allergic rhinitis with or without asthma

Exclusion criteria

Exclusion criteria: 1. Pregnant and lactating women; 2. In the past, house dust mite extract was used for treatment; 3. Patients who were given tefenadine, loratadine, fexofenadine, ebastine, cetirizine (who were given asmidazole within 3 months) within one week; 4. Patients who were treated with sodium salicylate, nedocromil or leukotriene receptor antagonists within two weeks.

Design outcomes

Primary

MeasureTime frame
allergen;—

Countries

China

Contacts

Public ContactWeitian Zhang

Shanghai Sixth People's Hospital

drzhangwt@163.com+86 18930177043

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026